Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2011, Article ID 982425, 7 pages
http://dx.doi.org/10.1155/2011/982425
Review Article

Autoantibodies to Tailor-Made Panels of Tumor-Associated Antigens in Breast Carcinoma

1Department of Obstetrics and Gynecology, Sapir Medical Center, Sackler School of Medicine, University of Tel-Aviv, Kfar-Saba 44281, Israel
2Unit of Gynecologic Oncology, Department of Obstetrics and Gynecology, Soroka Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84101, Israel

Received 31 October 2010; Accepted 14 January 2011

Academic Editor: Aysegula A. Sahin

Copyright © 2011 Ettie Piura and Benjamin Piura. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Lu, V. Goodell, and M. L. Disis, “Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancer,” Journal of Proteome Research, vol. 7, no. 4, pp. 1388–1394, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. A. Gagnon, J. H. Kim, J. O. Schorge et al., “Use of a combination of approaches to identify and validate relevant tumor-associated antigens and their corresponding autoantibodies in ovarian cancer patients,” Clinical Cancer Research, vol. 14, no. 3, pp. 764–771, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. C. Chapman, A. Murray, J. Chakrabarti et al., “Autoantibodies in breast cancer: their use as an aid to early diagnosis,” Annals of Oncology, vol. 18, no. 5, pp. 868–873, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. A. Jemal, R. Siegel, J. Xu, and E. Ward, “Cancer statistics, 2010,” CA Cancer Journal for Clinicians, vol. 60, no. 5, pp. 277–300, 2010. View at Publisher · View at Google Scholar · View at PubMed
  5. National Cancer Institute, “Fact Sheet,” http://www.cancer.gov/cancertopics/factsheet/Detection/probability-breast-cancer.
  6. National Cancer Institute, “Surveillance Epidemiology and End Results [SEER],” http://seer.cancer.gov/csr/1975_2007/browse_csr.php.
  7. J. Ferlay, H.-R. Shin, F. Bray, D. Forman, C. Mathers, and D. M. Parkin, “Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008,” International Journal of Cancer, vol. 127, no. 12, pp. 2893–2917, 2010. View at Publisher · View at Google Scholar
  8. B. Weigelt, F. C. Geyer, and J. S. Reis-Filho, “Histological types of breast cancer: how special are they?” Molecular Oncology, vol. 4, no. 3, pp. 192–208, 2010. View at Publisher · View at Google Scholar · View at PubMed
  9. J. P. Basuyau, M. P. Blanc-Vincent, J. M. Bidart et al., “Summary report of the standards, options and recommendations for the use of serum tumour markers in breast cancer: 2000,” British Journal of Cancer, vol. 89, supplement 1, pp. S32–S34, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. R. Molina, V. Barak, A. Van Dalen et al., “Tumor markers in breast cancer—European group on tumor markers recommendations,” Tumor Biology, vol. 26, no. 6, pp. 281–293, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. L. Harris, H. Fritsche, R. Mennel et al., “American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer,” Journal of Clinical Oncology, vol. 25, no. 33, pp. 5287–5312, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. C. M. Sturgeon, M. J. Duffy, U. H. Stenman et al., “National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers,” Clinical Chemistry, vol. 54, no. 12, pp. e11–e79, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. S. Chourin, D. Georgescu, C. Gray et al., “Value of CA 15-3 determination in the initial management of breast cancer patients,” Annals of Oncology, vol. 20, no. 5, pp. 962–964, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. E. Piura and B. Piura, “Autoantibodies to tumor-associated antigens in breast carcinoma,” Journal of Oncology, vol. 2010, Article ID 264926, 14 pages, 2010. View at Google Scholar
  15. J. Y. Zhang, C. A. Casiano, X. X. Peng, J. A. Koziol, E. K. L. Chan, and E. M. Tan, “Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens,” Cancer Epidemiology Biomarkers and Prevention, vol. 12, no. 2, pp. 136–143, 2003. View at Google Scholar · View at Scopus
  16. J. A. Koziol, J. Y. Zhang, C. A. Casiano et al., “Recursive partitioning as an approach to selection of immune markers for tumor diagnosis,” Clinical Cancer Research, vol. 9, no. 14, pp. 5120–5126, 2003. View at Google Scholar
  17. C. Desmetz, C. Bascoul-Mollevi, P. Rochaix et al., “Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women,” Clinical Cancer Research, vol. 15, no. 14, pp. 4733–4741, 2009. View at Publisher · View at Google Scholar · View at PubMed
  18. A. Yagihashi, T. Ohmura, K. Asanuma et al., “Detection of autoantibodies to survivin and livin in sera from patients with breast cancer,” Clinica Chimica Acta, vol. 362, no. 1-2, pp. 125–130, 2005. View at Publisher · View at Google Scholar · View at PubMed
  19. L. Zhong, K. Ge, J.-C. Zu et al., “Autoantibodies as potential biomarkers for breast cancer,” Breast Cancer Research, vol. 10, no. 3, 2008. View at Publisher · View at Google Scholar · View at PubMed
  20. K. Looi, R. Megliorino, F. D. Shi, X. X. Peng, Y. Chen, and J. Y. Zhang, “Humoral immune response to p16, a cyclin-dependent kinase inhibitor in human malignancies,” Oncology Reports, vol. 16, no. 5, pp. 1105–1110, 2006. View at Google Scholar
  21. C. A. Casiano, M. Mediavilla-Varela, and E. M. Tan, “Tumor-associated antigen arrays for the serological diagnosis of cancer,” Molecular and Cellular Proteomics, vol. 5, no. 10, pp. 1745–1759, 2006. View at Publisher · View at Google Scholar · View at PubMed
  22. H. Zhang and B. Singer, “Recursive Partitioning in the Health Sciences,” in Statistics for Biology and Health, Springer, New York, NY, USA, 1999. View at Google Scholar
  23. E. J. Atkinson and T. M. Therneau, “An introduction to recursive partitioning using the RPART routines,” Tech. Rep., Mayo Clinic Section of Biostatistics, Mayo Foundation, 2000, http://www.med.nyu.edu/biostatistics/people/Ilana%20Belitskaya-Levy/Courses/MAS/Handouts/RPART%20short.pdf. View at Google Scholar
  24. J. G. Elmore, K. Armstrong, C. D. Lehman, and S. W. Fletcher, “Screening for breast cancer,” Journal of the American Medical Association, vol. 293, no. 10, pp. 1245–1256, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. R. Smith-Bindman, P. Chu, D. L. Miglioretti et al., “Physician predictors of mammographic accuracy,” Journal of the National Cancer Institute, vol. 97, no. 5, pp. 358–367, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. A. Mavroforou, D. Mavrophoros, and E. Michalodimitrakis, “Screening mammography, public perceptions, and medical liability,” European Journal of Radiology, vol. 57, no. 3, pp. 428–435, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. P. T. Huynh, A. M. Jarolimek, and S. Daye, “The false-negative mammogram,” Radiographics, vol. 18, no. 5, pp. 1137–1154, 1998. View at Google Scholar · View at Scopus
  28. C. A. Beam, E. F. Conant, E. A. Sickles, and S. P. Weinstein, “Evaluation of proscriptive health care policy implementation in screening mammography,” Radiology, vol. 229, no. 2, pp. 534–540, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. C. J. D'Orsi, L. W. Bassett, W. A. Berg et al., Breast Imaging Reporting and Data System: ACR BI-RADS-Mammography, American College of Radiology, Reston, Va, USA, 4th edition, 2003.